Aridis Pharmaceuticals In... (ARDS)

AI Score

Unlock

0.00

-0.00 (-100.00%)

At close: Apr 01, 2025, 9:51 AM

Aridis Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017
Period Ending	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017
Net Income	-83K	12.14M	-6.82M	-6.39M	-8.24M	-7.98M	-7.77M	-8.81M	-21M	-5.49M	-6.89M	-5.82M	-5.79M	-4.22M	-6.5M	-5.65M	-7.59M	-8.38M	-8.06M	-5.44M	-7.91M	-1.42M	-7.33M	-4.94M	-5.42M	-6.08M	-8.21M
Depreciation & Amortization	59K	63K	87K	100K	125K	131K	131K	157K	94K	93K	91K	85K	85K	83K	84K	85K	87K	85K	81K	83K	76K	73K	51K	38K	14K	5K	5K
Stock-Based Compensation	200K	210K	245K	318K	349K	345K	467K	551K	580K	553K	567K	566K	562K	523K	477K	489K	535K	536K	450K	375K	428K	352K	503K	320K	236K	389K	663K
Other Working Capital	-791K	-19.45M	-1.07M	1.25M	3K	1.53M	-1.15M	2.26M	6.15M	-501K	955K	-362K	-967K	-339K	1.13M	9.57M	8.37M	866K	-1.77M	-2.53M	-518K	-286K	382K	-435K	118K	-275K	371K
Other Non-Cash Items	676K	69K	605K	-921K	823K	276K	366K	283K	6.46M	-722K	33K	16.5M	n/a	n/a	9K	41K	282K	186K	442K	40K	1.39M	-3.06M	38K	563K	-4K	2.18M	2.41M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	33K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-1.83M	-16.83M	1.88M	-1.67M	2.68M	1.05M	-3.36M	4.09M	5.28M	-1.04M	2.19M	77K	-445K	-1.61M	1.36M	8.7M	10.55M	-309K	-724K	-3.91M	1.3M	-2.21M	2.31M	-140K	782K	-2.19M	1.82M
Operating Cash Flow	-983K	-4.34M	-4M	-8.56M	-4.26M	-6.14M	-10.17M	-3.73M	-8.59M	-6.61M	-4.01M	-5.09M	-5.58M	-5.22M	-4.57M	3.67M	3.87M	-7.88M	-7.81M	-8.85M	-4.71M	-6.27M	-4.44M	-4.16M	-4.39M	-5.7M	-3.31M
Capital Expenditures	n/a	n/a	n/a	-49K	n/a	-12K	-21K	43K	-114K	-124K	-335K	-334K	-16K	-4K	-13K	-121K	-26K	93K	-120K	919K	242K	-647K	-272K	-288K	-410K	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	14K	n/a	-49K	n/a	-12K	-21K	43K	-114K	-124K	-335K	-334K	-16K	-4K	-13K	-121K	-26K	93K	-120K	-1M	242K	-647K	-272K	-288K	-410K	n/a	n/a
Debt Repayment	-735K	3.23M	-1.49M	-1.35M	-450K	n/a	5M	5M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-4.13M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-3K	-208K	-308K	-227K	-104K	-139K	-557K	4.13M	n/a	5K	n/a	n/a	n/a	715K	14K	18K	4.97M	n/a	8K	10K	25.08M	n/a	n/a	n/a	n/a	n/a	n/a
Financial Cash Flow	999K	3.03M	263K	11.03M	-554K	-139K	4.44M	4.95M	23.34M	-149K	6.58M	7.95M	n/a	715K	14K	18K	4.97M	n/a	8K	9K	25.08M	n/a	n/a	n/a	11.16M	5.4M	4.5M
Net Cash Flow	16K	-1.3M	-3.74M	2.43M	-4.82M	-6.29M	-5.74M	1.26M	14.63M	-6.88M	2.24M	2.52M	-5.6M	-4.51M	-4.57M	3.57M	8.81M	-7.79M	-7.93M	-9.84M	20.61M	-6.92M	-4.71M	-4.45M	6.37M	-298K	1.19M
Free Cash Flow	-983K	-4.34M	-4M	-8.61M	-4.26M	-6.15M	-10.19M	-3.69M	-8.71M	-6.73M	-4.34M	-5.43M	-5.6M	-5.23M	-4.59M	3.55M	3.84M	-7.79M	-7.93M	-7.93M	-4.47M	-6.92M	-4.71M	-4.45M	-4.8M	-5.7M	-3.31M